References
- AdairJEBeardBCTrobridgeGDExtended survival of glioblastoma patients after chemoprotective HSC gene therapySci Transl Med20124133133ra57
- MorganRADudleyMEWunderlichJRCancer regression in patients after transfer of genetically engineered lymphocytesScience2006314579612612916946036
- RobbinsPFMorganRAFeldmanSATumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1J Clin Oncol201129791792421282551
- GinnSLAlexanderIEEdelsteinMLAbediMRWixonJGene therapy clinical trials worldwide to 2012 – an updateJ Gene Med2013152657723355455
- LiRBurasELeeJGene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD miceGene Ther2015221187688226172077
- LiCZhangLChenYLinXLiTProtective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD miceExp Ther Med20161151625163227168782
- StewartDJHiltonJDArnoldJMAngiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatmentGene Ther200613211503151116791287
- SundararamanSMillerTJPastoreJMKiedrowskiMArasRPennMSPlasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failureGene Ther201118986787321472007
- BunnellBAMorganRAGene therapy for infectious diseasesClin Microbiol Rev199811142569457428
- HashibaTSuzukiMNagashimaYAdenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in miceGene Ther20018191499150711593363
- IvacikDElyAFerryNArbuthnotPSustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentivirusesGene Ther201522216317125338920
- WhiteheadKALangerRAndersonDGKnocking down barriers: advances in siRNA deliveryNat Rev Drug Discov20098212913819180106
- SoutschekJAkincABramlageBTherapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature2004432701417317815538359
- GaoSDagnaes-HansenFNielsenEJThe effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in miceMol Ther20091771225123319401674
- KawabataKTakakuraYHashidaMThe fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptakePharm Res19951268258307667185
- JafariMSoltaniMNaahidiSKarunaratneDNChenPNonviral approach for targeted nucleic acid deliveryCurr Med Chem201219219720822320298
- MellottAJForrestMLDetamoreMSPhysical non-viral gene delivery methods for tissue engineeringAnn Biomed Eng201341344646823099792
- GiaccaMZacchignaSVirus-mediated gene delivery for human gene therapyJ Control Release2012161237738822516095
- AtkinsonHChalmersRDelivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequencesGenetica2010138548549820084428
- DuanDSystemic delivery of adeno-associated viral vectorsCurr Opin Virol201621162527459604
- ChailertvanitkulVAPoutonCWAdenovirus: a blueprint for non-viral gene deliveryCurr Opin Biotechnol201021562763220638266
- ZhiDZhangSWangBZhaoYYangBYuSTransfection efficiency of cationic lipids with different hydrophobic domains in gene deliveryBioconjug Chem201021456357720121120
- RudzinskiWEAminabhaviTMChitosan as a carrier for targeted delivery of small interfering RNAInt J Pharm2010399111120732398
- ElzoghbyAOSamyWMElgindyNAProtein-based nanocarriers as promising drug and gene delivery systemsJ Control Release20121611384922564368
- YinLSongZKimKHReconfiguring the architectures of cationic helical polypeptides to control non-viral gene deliveryBiomaterials20133492340234923283350
- SunXZhangNCationic polymer optimization for efficient gene deliveryMini Rev Med Chem201010210812520408796
- DandekarPJainRKeilMCellular delivery of polynucleotides by cationic cyclodextrin polyrotaxanesJ Control Release2012164338739322789529
- YamadaHLoretzBLehrCMDesign of starch-graft-PEI polymers: an effective and biodegradable gene delivery platformBiomacromolecules20141551753176124684536
- HaoWLiuDShangYZhangJXuSLiuHpH-Triggered copolymer micelles as drug nanocarriers for intracellular deliveryRSC Adv20166352914929158
- WangSShenYZhangJXuSLiuHA designed lipopeptide with a leucine zipper as an imbedded on/off switch for lipid bilayersPhys Chem Chem Phys20161815101291013727009364
- LajunenTNurmiRKontturiLLight activated liposomes: functionality and prospects in ocular drug deliveryJ Control Release2016244pt B15716627565215
- MiYWolframJMuCEnzyme-responsive multistage vector for drug delivery to tumor tissuePharmacol Res2016113pt A929927546164
- HaoWHanXShangYXuSLiuHInsertion of pH-sensitive bola-type copolymer into liposome as a “stability anchor” for control of drug releaseColloids Surf B Biointerfaces201513680981626539807
- NeedhamDMcIntoshTJLasicDDRepulsive interactions and mechanical stability of polymer-grafted lipid membranesBiochim Biophys Acta19921108140481643080
- TorchilinVPOmelyanenkoVGPapisovMIPoly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevityBiochim Biophys Acta19941195111207918551
- ChengRMengFDengCKlokHAZhongZDual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug deliveryBiomaterials201334143647365723415642
- NavarroGPanJTorchilinVPMicelle-like nanoparticles as carriers for DNA and siRNAMol Pharm201512230131325557580
- VivekRThangamRNipunBabuVMultifunctional HER2-antibody conjugated polymeric nanocarrier- based drug delivery system for multi-drug-resistant breast cancer therapyACS Appl Mater Interfaces2014696469648024780315
- MünsterPNMarchionDCBassoADRosenNDegradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 30-kinase-AKT-dependent pathwayCancer Res200262113132313712036925
- LeeHDamDHHaJWYueJOdomTWEnhanced human epidermal growth factor receptor 2 degradation in breast cancer cells by lysosome-targeting gold nanoconstructsACS Nano20159109859986726335372
- MahlknechtGMaronRManciniMSchechterBSelaMYardenYAptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growthProc Natl Acad Sci U S A2013110208170817523630281
- RohHPippinJDrebinJADown-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neuCancer Res200060356056510676637
- YardenYSliwkowskiMXUntangling the ErbB signalling networkNat Rev Mol Cell Biol20012212713711252954
- McCloyRARogersSCaldonCELorcaTCastroABurgessAPartial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic eventsCell Cycle20141391400141224626186
- BurgessAVigneronSBrioudesELabbéJCLorcaTCastroALoss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balanceProc Natl Acad Sci U S A201010728125641256920538976
- FasmanGDCircular dichroism and the conformational analysis of biomoleculesPlenum19967215257
- LinPHYenSLLinMSMicrocalorimetrics studies of the thermodynamics and binding mechanism between L-tyrosinamide and aptamerJ Phys Chem B2008112216665667318457441
- NagatoishiSTanakaYTsumotoKCircular dichroism spectra demonstrate formation of the thrombin-binding DNA aptamer G-quadruplex under stabilizing-cation-deficient conditionsBiochem Biophys Res Commun2007352381281717150180
- NeveRMChinKFridlyandJA collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell200610651552717157791
- YoshimoriTYamamotoAMoriyamaYFutaiMTashiroYBafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cellsJ Biol Chem19912662617707177191832676
- DragowskaWHWepplerSAWangJCInduction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancerPLoS One2013810e7650324146879
- NahtaREstevaFJHerceptin: mechanisms of action and resistanceCancer Lett2006232212313816458110
- MengFZhongYChengRDengCZhongZpH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advancesNanomedicine (Lond)20149348749924746192
- LeeESGaoZYouHBRecent progress in tumor pH targeting nanotechnologyJ Control Release2008132316417018571265
- HiggsPGRNA secondary structure: physical and computational aspectsQ Rev Biophys200033200019925311191843
- MiyoshiDSugimotoNMolecular crowding effects on structure and stability of DNABiochimie20089071040105118331845